Intra Cellular Therapies | ITCI - Market Capitalization


Intra Cellular Therapies reported $12.77B in Market Capitalization this April of 2025, considering the latest stock price and the number of outstanding shares.



Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.8B 724M Mar/2026
ALKERMES USD 5.88B 1.26B Mar/2026
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
Biogen USD 26.9B 1.09B Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Cytokinetics USD 8.19B 420M Mar/2026
Esperion Therapeutics USD 885M 351M Dec/2025
Gilead Sciences USD 172.99B 20.71B Mar/2026
Halozyme Therapeutics USD 7.66B 257M Mar/2026
J&J USD 579.15B 78.91B Mar/2026
Nektar Therapeutics USD 11.91B 11.05B Jun/2026
Neurocrine Biosciences USD 13.25B 890M Mar/2026
RedHill Biopharma USD 1000K 4M Jun/2026
Supernus Pharmaceuticals USD 2.98B 126M Mar/2026
United Therapeutics USD 25.19B 4.21B Mar/2026
Vanda Pharmaceuticals USD 279M 6M Dec/2024